JDD Issue Highlights | May 2022
The May 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on skin cancer and features other topics such as fungal infections, updates on new topical advances, and Mohs micrographic surgery. We share this month’s issue highlights straight from the JDD Editor’s desk:
Insights in Skin of Color Patients With Atopic Dermatitis and the Role of Skincare in Improving Outcomes concludes …
The May 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on skin cancer and features other topics such as fungal infections, updates on new topical advances, and Mohs micrographic surgery. We share this month’s issue highlights straight from the JDD Editor’s desk:
Insights in Skin of Color Patients With Atopic Dermatitis and the Role of Skincare in Improving Outcomes concludes … 
During the 2021 Skin of Color Update virtual conference, Dr. Maritza Perez opened her lecture by sharing her goal: to assess what is known about skin cancer and photoprotection in people of color. Dr. Perez is a member of the American Academy of Dermatology, who commissioned a workforce to look into this subject.
What is known about the epidemiology of keratinocyte carcinomas in people of color? … 
At the 2021 Skin of Color Update, Dr. Heather Woolery-Lloyd, Director of the Skin of Color Division at the University of Miami Department of Dermatology, delivered an excellent talk on cosmeceutical recommendations for patients with diverse skin types, a personal favorite subject of hers. Catch the pearls of her talk here!
Hot Topics in Cosmeceuticals
Topical Cannabinoids – The skin has it … 
We all discuss sun protection with our patients. At this point, our recommendations are predictable – “avoidance, protective clothing, SPF 30+, broad-spectrum, water-resistant, and reapplication.” But how can we effectively change patient behavior?
Important note – this discussion has wide arching correlations to all areas of human behavior, medicine, and dermatology that spans more th … 
A patient in my clinic was recently prescribed 5-fluorouracil for severe photodamage, diffuse actinic keratoses. He is 24 years old and, unfortunately, lacked knowledge about photoprotection. It was sobering to think about how much longer he has to live and the damage already done. Strides have been made over the years in educating our patients about photoprotection, but recently, patients have … 